REQUEST A DEMO
Total
USD $0.00
Search more companies

Hippocrat Biotech Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hippocrat Biotech Private Limited Profile Updated: August 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Hippocrat Biotech Private Limited is based in India, with the head office in Thane. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on March 20, 2013. 13 (2026) employees currently work for Hippocrat Biotech Private Limited. The latest financial highlights indicate a net sales revenue increase of 20.63% in 2025. Its’ total assets recorded a growth of 92.73%.

Headquarters
G-4 Bldg D A Wing Raval Nagar Station Road Bhs Sai Apts Opposite Raval College Mira Road East Thane In-Mh In 401107
Thane; Maharashtra; Postal Code: 401107

Contact Details: Purchase the Hippocrat Biotech Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Hippocrat Biotech Private Limited report to view the information.
Registered Capital:
Purchase the Hippocrat Biotech Private Limited report to view the information.
Financial Auditors:
Purchase the Hippocrat Biotech Private Limited report to view the information.
Incorporation Date:
March 20, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Hippocrat Biotech Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
20.63%
Total Operating Revenue
20.63%
Operating Profit
45.66%
EBITDA
42.18%
Net Profit/Loss for the Period
20.03%
Total Assets
92.73%
Total Equity
8.63%
Operating Profit Margin
0.93%
Net Profit Margin
0%
Return on Equity (ROE)
0.76%
Debt / Equity
313.23%
Quick Ratio
3.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?